How your medications can change your blood test results.

Two different types of drug effects on tests

When a medication changes a lab result, it does so in one of two fundamentally different ways — and understanding which type matters greatly for how the result should be interpreted.

A pharmacological effect is the intended or known biological action of the drug. A statin lowers LDL cholesterol — this is expected and the "changed" result reflects successful treatment. An analytic interference is when the drug or its metabolite physically interferes with the laboratory measurement process, producing a result that does not reflect the true biological level.

Analytic interferences are more dangerous because they can cause a result to appear normal when the true value is abnormal (or vice versa), and the doctor may not suspect interference unless they know the patient is taking the offending drug.

Common medications and the tests they affect

The following are the most clinically significant drug-lab interactions encountered in routine practice.

Medications affecting hormone tests

Hormone levels are among the most medication-sensitive laboratory measurements. Several common drug classes directly alter circulating hormone levels.

Exogenous oestrogen (oral contraceptive pill, HRT) raises sex hormone-binding globulin (SHBG), which lowers free testosterone levels in both men and women. Total testosterone may be normal while free (biologically active) testosterone is low.

Dopamine antagonists (metoclopramide, antipsychotics including haloperidol and risperidone) raise prolactin levels substantially — sometimes above 1000 mIU/L, a level that would normally trigger investigation for a pituitary adenoma. Drug-induced hyperprolactinaemia must be excluded before imaging.

What to do before and at your blood test

Simple communication prevents the majority of medication-related result misinterpretations.

When booking your blood test, tell the receptionist or lab staff all medications and supplements you are currently taking. When you arrive, confirm this verbally with the phlebotomist so it can be noted on the request form.

If you receive a result that seems inconsistent with how you feel, ask your doctor whether your current medications could explain it. Most lab request forms have a medication field — filling it in thoroughly is one of the highest-yield steps a patient can take.

Anticoagulants and coagulation monitoring

Anticoagulant medications require specific laboratory monitoring and create unique interpretation challenges.

Warfarin is monitored by the INR — a test specifically designed to be comparable across laboratories regardless of the reagent used. The therapeutic range (usually INR 2.0–3.0 for AF or DVT) is a drug-effect target, not a reference range. An INR of 3.5 in a well-managed warfarin patient is expected, not alarming.

Direct oral anticoagulants (DOACs — apixaban, rivaroxaban, edoxaban, dabigatran) do not require routine monitoring, but significantly affect standard coagulation tests. If you take a DOAC and have blood drawn before surgery or in an emergency, the coagulation screen must be interpreted knowing you are anticoagulated.

Supplements and herbal products

Non-prescription supplements and herbal preparations are a frequently overlooked source of lab result interference.

St John's Wort is a potent inducer of CYP450 enzymes and P-glycoprotein. This lowers blood levels of drugs metabolised by these pathways — including cyclosporin, HIV antiretrovirals, and combined oral contraceptives. If a drug level is unexpectedly low and the patient takes St John's Wort, drug-herb interaction should be considered.

Omega-3 fatty acids at high doses (>3g/day) lower triglycerides measurably. Fish oil at lower doses has minimal effect on most standard tests but can slightly prolong bleeding time in some patients.

Timed drug levels and peak/trough testing

For some medications, the time of blood draw relative to the last dose is as important as the dose itself.

Trough levels are drawn immediately before the next scheduled dose — they measure the lowest point of drug concentration and confirm the drug is not falling below therapeutic range. Getting the timing wrong invalidates the result entirely.

Commonly monitored drugs requiring timed draws include: lithium (12 hours post-dose), vancomycin (trough before dose), tacrolimus and cyclosporin (trough before dose), digoxin (>6 hours post-dose), and methotrexate (48 and 72 hours post-dose for high-dose protocols).

A practical guide to medication disclosure before testing

Most medication-related result errors are preventable with complete disclosure.